PRESS-RELEASE ·Filed Apr 28, 2026

RDNT

RadNet, Inc.
BULLISH
Impact 7/10
Horizondays Processed5mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight ▲ Bullish

The massive EPS beat suggests strong operational performance, but historical T+20 returns on RDNT have been negative even on bullish calls. Monitor the Q1 2026 conference call on May 11 for guidance updates and margin trends before taking a directional position.

DirectionBullish
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
RDNT ▲ +5.34% at T+60d
LONG call ✓ call won +5.34% · α vs SPY +1.35% · entry $57.89 → $60.98
Entry anchored
Apr 28, 2026
via day open
T+1d
-3.45%
call -3.45% · α -3.44%
$55.89
settled 5mo ago
T+5d
+1.95%
call +1.95% · α +0.26%
$59.02
settled 5mo ago
T+20d
-7.00%
call -7.00% · α -12.45%
$53.84
settled 4mo ago
T+60d
+5.34%
call +5.34% · α +1.35%
$60.98
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

RadNet reported Q4 2025 EPS of $0.24, a 244.6% beat vs the $0.17 consensus, on revenue of $556.3M (in line with estimates). The strong earnings surprise is a positive signal, but the stock has historically not responded well to bullish calls on this ticker, with a 0% win rate at T+20 across prior reports.

Key Financial Metrics

EPS
$0.24
est $-0.17 · +244.6%
Revenue
$556.3M
est $556.3M · 0.0%
Rating
strong beat

Key Facts

  • EPS of $0.24 beat consensus of $0.17 by 244.6%
  • Revenue of $556.3M in line with estimates
  • Q4 2025 period ended December 31, 2025
  • Conference call for Q1 2026 results scheduled for May 11, 2026

Financial Impact

EPS surprise of +$0.41 per share vs consensus

epsrevenue

Risk Factors

  • Historical pattern shows poor T+20 performance on bullish calls for RDNT
  • Revenue was in line, not a beat — top-line growth may not support sustained upside
  • No guidance provided in this release; future quarters could disappoint

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
93% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3282356
14 reports for RDNT
Performance horizon
40% Hit rate 2 of 5 directional calls best @ T+60▲ +26.65%Jun 25, 2026
Filters
Rows
Reports for RDNT — sortable, filterable
TypeNow
Aug 10, 2026
7w ago
8-K
MIXED ★ 6/10
$77.28 $71.97▼ −6.87%▼ −5.96%$69.93 (−9.51%)
Aug 9, 2026
7w ago
Press Release
MIXED ★ 6/10
$77.28 $71.97▼ −6.87%▼ −5.96%$69.93 (−9.51%)
Jun 25, 2026
14w ago
Press Release
BULLISH ★ 5/10
$60.01 $60.98▲ +1.62%▲ +1.09%$69.93 (+16.53%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 5/10
$58.20 $65.94▲ +13.30%▲ +11.41%$69.93 (+20.15%)
Jun 3, 2026
17w ago
8-K
NEUTRAL ★ 4/10
$51.87 $68.75▲ +32.54%▲ +33.54%$69.93 (+34.82%)
May 11, 2026
20w ago
8-K
MIXED ★ 6/10
$55.90 $56.18▲ +0.50%▲ +0.81%$69.93 (+25.10%)
May 10, 2026
20w ago
Press Release
BULLISH ★ 7/10
$55.90 $56.18▲ +0.50%▲ +0.81%$69.93 (+25.10%)
Apr 28, 2026
22w ago
Press Release
BULLISH ★ 7/10
$57.89 $53.84▼ −7.00%▼ −12.45%$69.93 (+20.80%)
Apr 20, 2026
23w ago
DEFA14A
NEUTRAL ★ 3/10
$57.51 $54.17▼ −5.81%▼ −10.72%$69.93 (+21.60%)
Mar 11, 2026
29w ago
Press Release
NEUTRAL ★ 3/10
$59.78 $55.43▼ −7.28%▼ −9.25%$69.93 (+16.98%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (39h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 28, 2026